UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 20, 2008
Patriot Scientific Corporation
(Exact name of registrant as specified in its charter)
| Delaware | 0-22182 | 84-1070278 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
CARLSBAD CORPORATE PLAZA
6183 PASEO DEL NORTE, SUITE 180
CARLSBAD, CA 92011
(Address of principal executive offices, zip code)
(760) 547-2700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On August 20, 2008, Patriot Scientific Corporation (the “Company”) issued a press release announcing that the Company had engaged Imperial Capital, LLC, Los Angeles, California, as its financial advisor to assist the Company in identifying, and negotiating potential acquisition targets and to provide general financial advisory services related to possible acquisitions. A copy of the press release is attached hereto as exhibit 99.1.
On August 20, 2008, the Company issued a letter to shareholders and stakeholders providing an update on significant business activities at the Company. The letter focused on three topics: 1) an update on activities to expand Patriot Scientific’s future business prospects, 2) an update on Patriot’s plan to improve its investor relations (IR) and public relations (PR) program, and 3) comments on questions received from shareholders. A copy of the press release is attached hereto as exhibit 99.2.
The Company expressly disclaims any obligation to update these press releases and cautions that they were only accurate on the date they were presented. The inclusion of any data or statements in these press releases does not signify that the information is considered material.
Item 9.01 Financial Statements and Exhibits.
| | (d) Exhibits. |
| | |
| 99.1 | Press release dated August 20, 2008 |
| | |
| 99.2 | Press release dated August 20, 2008 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | Patriot Scientific Corporation (Registrant) | |
| | | | |
| Date: August 21, 2008 | By: | /s/ Clifford L. Flowers | |
| | | Clifford L. Flowers | |
| | | Chief Financial Officer | |
